1. Home
  2. IRWD vs CCNE Comparison

IRWD vs CCNE Comparison

Compare IRWD & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • CCNE
  • Stock Information
  • Founded
  • IRWD 1998
  • CCNE 1865
  • Country
  • IRWD United States
  • CCNE United States
  • Employees
  • IRWD N/A
  • CCNE N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • CCNE Major Banks
  • Sector
  • IRWD Health Care
  • CCNE Finance
  • Exchange
  • IRWD Nasdaq
  • CCNE Nasdaq
  • Market Cap
  • IRWD 510.5M
  • CCNE 595.8M
  • IPO Year
  • IRWD 2010
  • CCNE N/A
  • Fundamental
  • Price
  • IRWD $3.53
  • CCNE $26.89
  • Analyst Decision
  • IRWD Buy
  • CCNE Hold
  • Analyst Count
  • IRWD 4
  • CCNE 1
  • Target Price
  • IRWD $12.00
  • CCNE $30.00
  • AVG Volume (30 Days)
  • IRWD 1.9M
  • CCNE 46.5K
  • Earning Date
  • IRWD 02-13-2025
  • CCNE 01-21-2025
  • Dividend Yield
  • IRWD N/A
  • CCNE 2.59%
  • EPS Growth
  • IRWD N/A
  • CCNE N/A
  • EPS
  • IRWD N/A
  • CCNE 2.33
  • Revenue
  • IRWD $378,418,000.00
  • CCNE $216,515,000.00
  • Revenue This Year
  • IRWD N/A
  • CCNE N/A
  • Revenue Next Year
  • IRWD N/A
  • CCNE $8.80
  • P/E Ratio
  • IRWD N/A
  • CCNE $11.53
  • Revenue Growth
  • IRWD N/A
  • CCNE N/A
  • 52 Week Low
  • IRWD $3.06
  • CCNE $17.74
  • 52 Week High
  • IRWD $15.70
  • CCNE $29.29
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 44.66
  • CCNE 44.28
  • Support Level
  • IRWD $3.39
  • CCNE $27.00
  • Resistance Level
  • IRWD $4.05
  • CCNE $27.68
  • Average True Range (ATR)
  • IRWD 0.30
  • CCNE 0.60
  • MACD
  • IRWD 0.02
  • CCNE -0.19
  • Stochastic Oscillator
  • IRWD 47.47
  • CCNE 5.92

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. In addition, the corporation provides wealth and asset management services, retirement plans and other employee benefit plans.

Share on Social Networks: